TY - JOUR T1 - Estrogen Regulation of the Cytochrome P450 3A Subfamily in Humans JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther SP - 728 LP - 735 DO - 10.1124/jpet.104.068908 VL - 311 IS - 2 AU - Eric T. Williams AU - Malgorzata Leyk AU - Steven A. Wrighton AU - Peter J. A. Davies AU - David S. Loose AU - Gregory L. Shipley AU - Henry W. Strobel Y1 - 2004/11/01 UR - http://jpet.aspetjournals.org/content/311/2/728.abstract N2 - This study examines the possible role of estrogen in regulating the expression of the human CYP3A subfamily: CYP3A4, CYP3A5, CYP3A7, and CYP3A43. To accomplish this goal, mRNA was quantified from human livers and endometrial samples, and total CYP3A protein levels were evaluated by Western immunoblot analysis of the liver samples. The human endometrial samples were from premenopausal and postmenopausal women. The premenopausal endometrium was either in the proliferative or secretory phase, whereas for the postmenopausal endometrium samples, the women had been treated with either a placebo or estropipate, an estrogen substitute. After analyses, CYP3A4 mRNA was shown to have lower hepatic expression in females than in males. In the endometrium, CYP3A4 and CYP3A43 are down-regulated by estrogen, whereas CYP3A5 is expressed at higher levels during the secretory phase. CYP3A7 was not detected in the endometrium. In addition, the CYP3A subfamily showed increased mRNA expression in the liver as age increased. The expression levels of total CYP3A protein and total CYP3A mRNA showed good correlation. Despite apparent regulation of CYP3A4 mRNA expression by estrogen, the effects of estrogen may be overshadowed by additional regulators of gene expression. The American Society for Pharmacology and Experimental Therapeutics ER -